ATX West, MD&M West, Plastec West, West Pack, and Design & Manufacturing West is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Welcome to the ATX West Presentation Store. Here you can view and download conference and/or show floor theater presentations before, during, and after the event. If you’re looking for a presentation from a specific session that you’re unable to find here, note that it’s likely because the presenter has not provided permission for external use or has not yet shared their presentation with us. Please check back after the event for a more complete catalogue of available presentations.

Patrick GanzerPrincipal Research Scientist & Bioelectronic Medicine LeadBatelle

Dr. Ganzer received his BS in Neuroscience from King’s College in 2008 (Summa Cum Laude), completed his Ph.D. in Biomedical Engineering and Science from Drexel University in 2013, and finished his post-doctoral fellowship at the University of Texas at Dallas in 2017. He is now a Principal Research Scientist at Battelle Memorial Institute, the world’s largest non-profit research organization located in Columbus, Ohio. Dr. Ganzer is currently the Principal Investigator for Battelle’s Bioelectronic Medicine program – a research and development initiative focusing on developing bioelectronic medicine therapies for treating disease. His previous research at the University of Texas at Dallas utilized targeted vagus nerve stimulation to boost the effects of rehab and restore connections to paralyzed muscles in preclinical models of spinal cord injury, stroke, and peripheral nerve injury. Dr. Ganzer’s work is now being translated to multiple clinical trial applications, and has been enabled by over $4 million dollars in funding from agencies such as the Defense Advanced Research Projects Agency (DARPA), the Wing’s for Life Foundation, and the W.W. Caruth Jr. Foundation. With his talented teammates, Patrick is developing new neurotechnologies and bioelectronic medicines to treat patients suffering from dysfunction and disease.